PL426821A1 - Peptide, application of this peptide and a composition that contains this peptide - Google Patents
Peptide, application of this peptide and a composition that contains this peptideInfo
- Publication number
- PL426821A1 PL426821A1 PL426821A PL42682112A PL426821A1 PL 426821 A1 PL426821 A1 PL 426821A1 PL 426821 A PL426821 A PL 426821A PL 42682112 A PL42682112 A PL 42682112A PL 426821 A1 PL426821 A1 PL 426821A1
- Authority
- PL
- Poland
- Prior art keywords
- peptide
- composition
- application
- sequence
- ovalbumin
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Przedmiotem wynalazku jest peptyd zawierający sekwencję Asp-Ile-Leu-Asn, odpowiadający fragmentowi 86-89 owoalbuminy. Uzyskany peptyd wykazuje aktywność przeciwutleniającą poprzez wiązanie wolnych rodników oraz chelatowanie kationów dwuwartościowych. Sekwencja peptydu, ze względu na swoje właściwości, może być szeroko wykorzystana zarówno w przemyśle farmaceutycznym, spożywczym i kosmetycznym.The present invention relates to a peptide comprising the sequence Asp-Ile-Leu-Asn, corresponding to fragment 86-89 of ovalbumin. The resulting peptide has antioxidant activity by binding free radicals and chelating divalent cations. The peptide sequence, due to its properties, can be widely used in both the pharmaceutical, food and cosmetics industries.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL426821A PL233101B1 (en) | 2012-10-01 | 2012-10-01 | Peptide, application of this peptide and a composition that contains this peptide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL426821A PL233101B1 (en) | 2012-10-01 | 2012-10-01 | Peptide, application of this peptide and a composition that contains this peptide |
Publications (2)
Publication Number | Publication Date |
---|---|
PL426821A1 true PL426821A1 (en) | 2018-11-05 |
PL233101B1 PL233101B1 (en) | 2019-09-30 |
Family
ID=63998354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL426821A PL233101B1 (en) | 2012-10-01 | 2012-10-01 | Peptide, application of this peptide and a composition that contains this peptide |
Country Status (1)
Country | Link |
---|---|
PL (1) | PL233101B1 (en) |
-
2012
- 2012-10-01 PL PL426821A patent/PL233101B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL233101B1 (en) | 2019-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021010033A (en) | Microencapsulated cannabinoid compositions. | |
PH12015502553A1 (en) | Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof | |
EA201690314A1 (en) | ANTI-GARP-PROTEIN AND ITS APPLICATIONS | |
MX371497B (en) | Compositions and methods comprising a lipolytic enzyme variant. | |
MX2015011075A (en) | Therapeutic peptides. | |
PH12014501942A1 (en) | Cereal pieces containing alpha-linolenic acid | |
MX2020009223A (en) | Afucosylated anti-fgfr2iiib antibodies. | |
EA201490644A1 (en) | THERAPEUTIC PEPTIDES | |
IN2015DN03322A (en) | ||
EA201492221A1 (en) | POLYPEPTIDES THAT HAVE A TRANSGALACTOSIS ACTIVITY | |
MX2018000590A (en) | Antibody molecules which bind cd79. | |
HUE038906T2 (en) | Caseinomacropeptide-containing, high protein denatured whey protein compositions, products containing them, and uses thereof | |
MX2017012596A (en) | A pharmaceutical composition and the use thereof. | |
MX350970B (en) | Methods and compositions for extending shelf life of plant products. | |
BR112015027824A2 (en) | vitamin e powder compositions | |
FR2977256B1 (en) | COMPOSITIONS OF 2,4,4,4-TETRAFLUOROBUT-1-ENE AND CIS-1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE | |
PH12015501099A1 (en) | Synbiotic composition and use thereof | |
NZ717927A (en) | Compositions for the treatment of hypertension and/or fibrosis | |
ZA201504748B (en) | New antibody fragments, compositions and uses thereof | |
MX2014009244A (en) | A composition and use thereof in the treatment of anal rhagades. | |
EP2569327A4 (en) | Eif4e binding peptides | |
PH12015501147A1 (en) | Synbiotic composition and use thereof | |
PL426821A1 (en) | Peptide, application of this peptide and a composition that contains this peptide | |
MX2015009385A (en) | Compositions comprising heat-treated clear tomato concentrate. | |
MX2018005783A (en) | Hemostatic composition. |